Bob Chapek, chief executive officer of Disney, speaks at the 2022 Disney Legends Awards during Disney's D23 Expo in Anaheim,
Bentley delays all-EV plan past 2030 amid vehicle development issues
Bentley Continental GTC Speed in Kingfisher.Adam Jeffery | CNBCBentley Motors is pushing back its plans to exclusively offer all-electric vehicles
George Lucas backs Disney CEO Bob Iger in Nelson Peltz proxy fight
Filmmaker and Hollywood legend George Lucas is throwing his support behind Walt Disney CEO Bob Iger in the bitter proxy
Where cracks in the banking sector may appear without more M&A
The forces that consumed three regional lenders in March 2023 have left hundreds of smaller banks wounded, as merger activity
Homebuilder sentiment turns positive for the first time since July
U.S. homebuilders are feeling more confident about their businesses than they have since last summer, as they see better demand
Morgan Stanley names head of artificial intelligence, Jeff McMillan
The Morgan Stanley digital sign is seen at the company's Times Square headquarters in New York, U.S., on Friday, Jan.
SpaceX Starship rocket flies milestone third test flight
The SpaceX Starship spacecraft lifts off from Starbase in Boca Chica, Texas, on March 14, 2024.Chandan Khanna | AFP |
SpaceX cleared to attempt third Starship launch Thursday
SpaceX's next-generation Starship spacecraft atop its powerful Super Heavy rocket is prepared for a third launch from the company's Boca
Online marketplaces can do more to stop crime
Read CNBC's full investigation into the alleged organized theft groups that police say are stealing and reselling items from retailers
Empty middle seats, more legroom
A Frontier Airlines plane lands at the McCarran International Airport in Las Vegas on Thursday, Feb. 27, 2020. Elizabeth Page Brumley
Inside organized crime rings targeting retailers Ulta, TJX, Walgreens
In a tony suburban enclave in the San Diego foothills, police say, an organized retail crime "queenpin" had built an
Weight loss pill could become a best-in-class drug
Novo Nordisk CEO Lars Fruergaard Jørgensen on Friday said the company's experimental weight loss pill, amycretin, could eventually become a